Melanoma May No Longer Be a Death Sentence

REPLAY VIDEO
Your next video will start in
Pause
  • Info

  • Comments

June 3 (Bloomberg) -- The next generation of experimental immune-boosting drugs from Merck, Bristol-Myers and Roche are producing such promising early results that doctors are openly speculating that some patients with the deadliest form of skin cancer may be cured. Olivia Sterns reports on Bloomberg Television's "Street Smart." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change